Clinical Trial Update: SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of SCLife®-LDD hUC-MSCs Injection Therapy for lumbar intervertebral disc degeneration has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Intervertebral Disc Degeneration

Drugs mentioned

• SCLife®-LDD hUC-MSCs Injection Therapy (human umbilical cord mesenchymal stem cell (hUC-MSC) injection therapy)

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Lumbar Disc Degeneration | Phase 1 | Status: SUSPENDED